General



As previously disclosed, on July 1, 2022, we completed our combination with
Elkay Manufacturing Company ("Elkay") through the merger of Elkay with and into
a newly created subsidiary of the Company, with Elkay surviving as a wholly
owned subsidiary of Zurn Elkay (the "Merger" or "Elkay Transaction"). In
conjunction with the Merger, we changed our name from Zurn Water Solutions
Corporation to Zurn Elkay Water Solutions Corporation. Our results of operations
will include the acquired operations subsequent to July 1, 2022. See Item 1,
Note 18, Subsequent Events for additional information on the Elkay Transaction.

Following the merger with Elkay, Zurn Elkay is a growth-oriented, pure-play
water management business that designs, procures, manufactures, and markets what
we believe to be the broadest sustainable product portfolio of
specification-driven water management solutions to improve health, human safety
and the environment. Our product portfolio includes professional grade water
control and safety, water distribution and drainage, drinking water, finish
plumbing, hygienic, environmental and site works products for public and private
spaces that deliver superior value to building owners, positively impact the
environment and human hygiene and reduce product installation time. Our heritage
of innovation and specification has allowed us to provide highly-engineered,
mission-critical solutions to customers for decades and affords us the privilege
of having long-term, valued relationships with market leaders. We operate in a
disciplined way and the Zurn Elkay Business System ("ZEBS"), described below, is
our operating philosophy. Grounded in the spirit of continuous improvement, ZEBS
creates a scalable, process-based framework that focuses on driving superior
customer satisfaction and financial results by targeting world-class operating
performance throughout all aspects of our business.

The following information should be read in conjunction with the audited consolidated financial statements and notes thereto, along with Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A"), in our Annual Report on Form 10-K for the year ended December 31, 2021.

Critical Accounting Policies and Estimates



  The condensed consolidated financial statements have been prepared in
accordance with accounting principles generally accepted in the United States
("GAAP"), which require us to make estimates and assumptions that affect the
reported amounts of assets and liabilities on the date of the financial
statements and revenues and expenses during the periods reported. Actual results
could differ from those estimates. Refer to Item 7, MD&A, of our Annual Report
on Form 10-K for the year ended December 31, 2021 for information with respect
to our critical accounting policies which we believe could have the most
significant effect on our reported results and require subjective or complex
judgments by management. Except for the items reported below, management
believes that as of June 30, 2022, and during the period from January 1, 2022
through June 30, 2022, there has been no material change to this information.

Recent Accounting Pronouncements

See Item 1, Note 1, Basis of Presentation and Significant Accounting Policies regarding recent accounting pronouncements.

Acquisitions



On November 17, 2021, we completed the acquisition of the Wade Drains business
("Wade Drains") from McWane, Inc. for a cash purchase price of $12.6 million,
excluding transaction costs and net of cash acquired. During the six months
ended June 30, 2022, we received a $1.1 million cash payment from the sellers of
Wade Drains in connection with finalizing the acquisition date trade working
capital, which is included in the total cash purchase price above. Wade Drains
manufactures a wide range of specified commercial plumbing products for
customers across North America and complements our existing flow systems product
portfolio.

On April 16, 2021, we acquired substantially all of the assets of Advance
Technology Solutions, LLC (d/b/a ATS GREASEwatch) ("ATS GREASEwatch") for a
total cash purchase price of $4.5 million. ATS GREASEwatch, headquartered in
Saginaw, Michigan, develops, manufactures and markets remote tank monitoring
devices, alarms, software and services for various applications and provides
technology to enhance and expand our current product offerings within our
existing product portfolio.

                                       23
--------------------------------------------------------------------------------
  Table of Contents
Spin-Off of Process & Motion Control Segment

On October 4, 2021, we completed a Reverse Morris Trust tax-free spin-off
transaction (the "Spin-off Transaction") in which (i) substantially all the
assets and liabilities of our Process & Motion Control ("PMC") business were
transferred to a newly created subsidiary, Land Newco, Inc. ("Land"), (ii) the
shares of Land were distributed to our stockholders pro rata, and (iii) Land was
merged with a subsidiary of Regal Rexnord Corporation (formerly known as Regal
Beloit Corporation), in which the stock of Land was converted into a specified
number of shares of Regal Rexnord Corporation. During the six months ended June
30, 2022, we received $35.0 million from Regal Rexnord Corporation as a result
of the final working capital and cash balances at closing exceeding the targets
stipulated in the Spin-Off Transaction agreement.

The operating results of PMC are reported as discontinued operations in our
condensed consolidated statements of operations for all periods presented. The
condensed consolidated statements of cash flows for the period ended June 30,
2021 has not been adjusted to separately disclose cash flows related to the
discontinued operations. See Item 1, Note 4, Discontinued Operations for
additional information on cash flows associated with the discontinued
operations.

The major components of the Income from discontinued operations, net of tax
presented in the condensed consolidated statements of operations for the three
and six months ended June 30, 2022 and June 30, 2021, are as follows (in
millions):

                                                    Three Months Ended                             Six Months Ended
                                           June 30, 2022         June 30, 2021           June 30, 2022           June 30, 2021
Net sales                                  $        -          $        324.6          $         -             $        645.5
Cost of sales                                       -                  (192.6)                   -                     (394.0)
Selling, general and administrative
expenses                                            -                   (61.6)                   -                     (123.2)
Restructuring and other similar charges             -                    (0.8)                   -                       (0.8)
Amortization of intangible assets                   -                    (3.3)                   -                       (6.6)
Interest expense, net                               -                    (1.6)                   -                       (3.0)

Other non-operating income, net                     -                     2.1                    -                        1.4
Income from discontinued operations before
income tax                                          -                    66.8                    -                      119.3

Income tax (provision) benefit                      -                   (14.3)                 0.8                      (26.8)
Equity method investment income                     -                     0.2                    -                        0.3
Non-controlling interest income                     -                     0.1                    -                        0.2
Income from discontinued operations, net
of tax                                     $        -          $         52.6          $       0.8             $         92.6



Results of Operations

Three Months Ended June 30, 2022 compared with the Three Months Ended June 30, 2021:



Net sales

(Dollars in Millions)


                     Three Months Ended
             June 30, 2022       June 30, 2021       Change      % Change

Net Sales $ 284.2 $ 243.7 $ 40.5 16.6 %




Net sales were $284.2 million during the three months ended June 30, 2022, an
increase of 17% year over year. Excluding a 2% increase to net sales resulting
from our prior-year acquisition, core sales increased 15% year over year as
nearly all of our product categories contributed to the sales growth.

                                       24
--------------------------------------------------------------------------------

  Table of Contents
Income from operations

(Dollars in Millions)
                                   Three Months Ended
                            June 30, 2022       June 30, 2021      Change       % Change
Income from operations     $       53.5        $       37.3       $ 16.2          43.4  %
  % of net sales                   18.8   %            15.3  %       3.5  %


Income from operations was $53.5 million during the three months ended June 30,
2022, or 18.8% of net sales. Income from operations as a percentage of net sales
increased by 350 basis points primarily as a result of the favorable impact of
year-over-year sales growth (inclusive of price realization), productivity
savings and the lower intangible asset amortization and non-cash stock-based
compensation expense, all of which was partially offset by the year-over-year
increases in material and transportation costs, as well as incremental growth
and productivity investments.

Interest expense, net

  Interest expense, net was $5.2 million during the three months ended June 30,
2022, compared to $10.1 million during the three months ended June 30, 2021. The
decrease in interest expense as compared to the prior year period is primarily a
result of the lower outstanding borrowings following the Spin-Off Transaction
refinancing, partially offset by a higher year over year interest rate. See Item
1, Note 13 Long-Term Debt for more information.

Other expense, net



  Other expense, net during the three months ended June 30, 2022 and 2021, was
$0.6 million and $0.4 million, respectively. Other expense, net consists
primarily of foreign currency transaction gains and losses and the non-service
cost components associated with our defined benefit plans.

Provision for income taxes



The income tax provision was $11.3 million for the three months ended June 30,
2022, compared to $6.2 million for the three months ended June 30, 2021. The
effective income tax rate for the three months ended June 30, 2022 was 23.7%
versus 23.1% for the three months ended June 30, 2021. The effective income tax
rate for the three months ended June 30, 2022 was above the U.S. federal
statutory rate of 21% primarily due to the accrual of foreign income taxes,
which are generally above the U.S. federal statutory rate, the accrual of
additional income taxes associated with compensation deduction limitations under
Section 162(m) of the Internal Revenue Code, and the accrual of various state
income taxes, partially offset by the recognition of income tax benefits
associated with share-based payments. The effective income tax rate for the
three months ended June 30, 2021 was above the U.S. federal statutory rate of
21% primarily due to the accrual of foreign income taxes, which are generally
above the U.S. federal statutory rate, the accrual of additional income taxes
associated with compensation deduction limitations under Section 162(m) of the
Internal Revenue Code, and the accrual of various state income taxes, partially
offset by the recognition of income tax benefits associated with share-based
payments.

On a quarterly basis, we review and analyze our valuation allowances associated
with deferred tax assets relating to certain foreign and state net operating
loss carryforwards as well as U.S. federal and state capital loss carryforwards.
In conjunction with this analysis, we weigh both positive and negative evidence
for purposes of determining the proper balances of such valuation allowances.
Future changes to the balances of these valuation allowances, as a result of our
continued review and analysis, could result in a material impact to the
financial statements for such period of change.

Net income attributable to Zurn Elkay common stockholders



  Net income attributable to Zurn Elkay common stockholders during the three
months ended June 30, 2022, was $36.4 million compared to $73.2 million during
the three months ended June 30, 2021. Diluted net income per share attributable
to Zurn Elkay common stockholders for the three months ended June 30, 2022 and
June 30, 2021, was $0.28 and $0.59, respectively. The year over year change is
the result of the PMC operations classified as discontinued operations in the
prior year and the other factors described above. Net income from discontinued
operations, net of tax, was $0.0 million for the three months ended June 30,
2022 compared to $52.6 million for the three months ended June 30, 2021. Diluted
net income per share from discontinued operations for the three months ended
June 30, 2022 and June 30, 2021, was $0.00 and $0.42, respectively.


                                       25

--------------------------------------------------------------------------------

Table of Contents Six Months Ended June 30, 2022 compared with the Six Months Ended June 30, 2021:



Net sales

(Dollars in Millions)


                      Six Months Ended
             June 30, 2022       June 30, 2021       Change      % Change

Net Sales $ 523.8 $ 448.9 $ 74.9 16.7 %




Net sales were $523.8 million during the six months ended June 30, 2022, an
increase of 17% year over year. Excluding a 2% increase in net sales resulting
from our prior-year acquisition, core sales increased 15% as nearly all of our
product categories contributed to the sales growth.

Income from operations

(Dollars in Millions)

                                     Six Months Ended
                             June 30, 2022       June 30, 2021      Change      % Change
Income from operations               97.4               61.3        36.1          58.9  %
  % of net sales                     18.6  %            13.7  %      4.9  %


Income from operations was $97.4 million during the six months ended June 30,
2022, or 18.6% of net sales. Income from operations as a percentage of net sales
increased by 490 basis points primarily as a result of the favorable impact of
year-over-year sales growth (inclusive of price realization), productivity
savings, lower non-cash stock-based compensation expense, lower intangible asset
amortization and the year-over-year change in the adjustment to state
inventories at last-in-first-out cost, all of which was partially offset by the
year-over-year increases in material and transportation costs, as well as
incremental growth and productivity investments.

Interest expense, net



  Interest expense, net was $10.0 million during the six months ended June 30,
2022, compared to $19.7 million during the six months ended June 30, 2021. The
decrease in interest expense as compared to the prior year period is primarily a
result of the lower outstanding borrowings following the Spin-Off Transaction
refinancing, partially offset by a higher year over year interest rate. See Item
1, Note 13 Long-Term Debt for more information.

Other expense, net

Other expense, net during the six months ended June 30, 2022 and 2021 was $0.3 million and $0.1 million, respectively. Other expense, net consists primarily of foreign currency transaction gains and losses and the non-service cost components associated with our defined benefit plans.

Provision for income taxes



The income tax provision was $21.3 million during the six months ended June 30,
2022, compared to $10.9 million in the six months ended June 30, 2021. The
effective income tax rate for the six months ended June 30, 2022 was 24.5%
versus 26.3% in the six months ended June 30, 2021. The effective income tax
rate for the six months ended June 30, 2022 was above the U.S. federal statutory
rate of 21% primarily due to the accrual of foreign income taxes, which are
generally above the U.S. federal statutory rate, the accrual of additional
income taxes associated with compensation deduction limitations under Section
162(m) of the Internal Revenue Code and the accrual of various state income
taxes, partially offset by the recognition of income tax benefits associated
with share-based payments. The effective income tax rate for the six months
ended June 30, 2021 was above the U.S. federal statutory rate of 21% primarily
due to the accrual of foreign income taxes, which are generally above the U.S.
federal statutory rate, the accrual of additional income taxes associated with
compensation deduction limitations under Section 162(m) of the Internal Revenue
Code, and the accrual of various state income taxes, partially offset by the
recognition of income tax benefits associated with share-based payments.


                                       26
--------------------------------------------------------------------------------
  Table of Contents
Net income attributable to Zurn Elkay common stockholders

  Net income attributable to Zurn Elkay common stockholders during the six
months ended June 30, 2022, was $66.6 million compared to $123.2 million during
the six months ended June 30, 2021. Diluted net income per share attributable to
Zurn Elkay common stockholders for the six months ended June 30, 2022 and
June 30, 2021, was $0.52 and $0.99, respectively. The year over year change is
the result of the PMC operations classified as discontinued operations in the
prior year and the other factors described above. Net income from discontinued
operations, net of tax, was $0.8 million for the six months ended June 30, 2022
compared to $92.6 million for the six months ended June 30, 2021. Diluted net
income per share from discontinued operations for the six months ended June 30,
2022 and June 30, 2021, was $0.01 and $0.75, respectively.


Non-GAAP Financial Measures



  Non-GAAP financial measures are intended to supplement and not replace
financial measures prepared in accordance with GAAP. The following non-GAAP
financial measures are utilized by management in comparing our operating
performance on a consistent basis. We believe that these financial measures are
appropriate to enhance an overall understanding of our underlying operating
performance trends compared to historical and prospective periods and our peers.
Management also believes that these measures are useful to investors in their
analysis of our results of operations and provide improved comparability between
fiscal periods as well as insight into the compliance with our debt covenants.
Non-GAAP financial measures should not be considered in isolation from, or as a
substitute for, financial information calculated in accordance with GAAP.
Investors are encouraged to review the reconciliation of these non-GAAP measures
to their most directly comparable GAAP financial measures.

Core sales



  Core sales excludes the impact of acquisitions (such as the Wade Drains
acquisition), divestitures and foreign currency translation. Management believes
that core sales facilitates easier and more meaningful comparisons of our net
sales performance with prior and future periods and to our peers. We exclude the
effect of acquisitions and divestitures because the nature, size and number of
acquisitions and divestitures can vary dramatically from period to period and
between us and our peers, and can also obscure underlying business trends and
make comparisons of long-term performance difficult. We exclude the effect of
foreign currency translation from this measure because the volatility of
currency translation is not under management's control.

EBITDA



  EBITDA represents earnings before interest and other debt related activities,
taxes, depreciation and amortization. EBITDA is presented because it is an
important supplemental measure of performance and it is frequently used by
analysts, investors and other interested parties in the evaluation of companies
in our industry. EBITDA is also presented and compared by analysts and investors
in evaluating our ability to meet debt service obligations. Other companies in
our industry may calculate EBITDA differently. EBITDA is not a measurement of
financial performance under GAAP and should not be considered as an alternative
to cash flow from operating activities or as a measure of liquidity or an
alternative to net income as indicators of operating performance or any other
measures of performance derived in accordance with GAAP. Because EBITDA is
calculated before recurring cash charges, including interest expense and taxes,
and is not adjusted for capital expenditures or other recurring cash
requirements of the business, it should not be considered as a measure of
discretionary cash available to invest in the growth of the business.

Adjusted EBITDA



  Adjusted EBITDA (as described below in "Covenant Compliance") is an important
measure because, under our credit agreement, our ability to incur certain types
of acquisition debt and certain types of subordinated debt, make certain types
of acquisitions or asset exchanges, operate our business and make dividends or
other distributions, all of which will impact our financial performance, is
impacted by our Adjusted EBITDA, as our lenders measure our performance with a
net first lien leverage ratio by comparing our senior secured bank indebtedness
to our Adjusted EBITDA (see "Covenant Compliance" for additional discussion of
this ratio, including a reconciliation to our net income). We reported net
income attributable to Zurn Elkay common stockholders in the six months ended
June 30, 2022, of $66.6 million and Adjusted EBITDA for the same period of
$116.3 million. See "Covenant Compliance" for a reconciliation of Adjusted
EBITDA to GAAP net income.

Covenant Compliance



  Our credit agreement, which governs our senior secured credit facilities,
contains, among other provisions, restrictive covenants regarding indebtedness,
payments and distributions, mergers and acquisitions, asset sales, affiliate
transactions, capital expenditures and the maintenance of certain financial
ratios. Payment of borrowings under the credit agreement may be accelerated if
there is an event of default. Events of default include the failure to pay
principal and interest when due, a material breach of a representation or
warranty, certain non-payments or defaults under other indebtedness, covenant
defaults, events of

                                       27
--------------------------------------------------------------------------------
  Table of Contents
bankruptcy and a change of control. Certain covenants contained in the credit
agreement restrict our ability to take certain actions, such as incurring
additional debt or making acquisitions, if we are unable to meet a maximum total
net leverage ratio of 5.00 to 1.00 as of the end of each fiscal quarter. At
June 30, 2022, our net leverage ratio was 2.08 to 1.00. Failure to comply with
these covenants could limit our long-term growth prospects by hindering our
ability to borrow under the revolver, to obtain future debt and/or to make
acquisitions.

  "Adjusted EBITDA" is the term we use to describe EBITDA as defined and
adjusted in our credit agreement, which is net income, adjusted for the items
summarized in the table below. Adjusted EBITDA is intended to show our
unleveraged, pre-tax operating results and therefore reflects our financial
performance based on operational factors, excluding non-operational, non-cash or
non-recurring losses or gains. In view of our debt level, it is also provided to
aid investors in understanding our compliance with our debt covenants. Adjusted
EBITDA is not a presentation made in accordance with GAAP, and our use of the
term Adjusted EBITDA varies from others in our industry. This measure should not
be considered as an alternative to net income, income from operations or any
other performance measures derived in accordance with GAAP. Adjusted EBITDA has
important limitations as an analytical tool, and should not be considered in
isolation, or as a substitute for analysis of our results as reported under
GAAP. For example, Adjusted EBITDA does not reflect: (a) our capital
expenditures, future requirements for capital expenditures or contractual
commitments; (b) changes in, or cash requirements for, our working capital
needs; (c) the significant interest expenses, or the cash requirements necessary
to service interest or principal payments, on our debt; (d) tax payments that
represent a reduction in cash available to us; (e) any cash requirements for the
assets being depreciated and amortized that may have to be replaced in the
future; or (f) the impact of earnings or charges resulting from matters that we
and the lenders under our credit agreement may not consider indicative of our
ongoing operations. In particular, our definition of Adjusted EBITDA allows us
to add back certain non-cash, non-operating or non-recurring charges that are
deducted in calculating net income, even though these are expenses that may
recur, vary greatly and are difficult to predict and can represent the effect of
long-term strategies as opposed to short-term results.

  In addition, certain of these expenses can represent the reduction of cash
that could be used for other corporate purposes. Further, although not included
in the calculation of Adjusted EBITDA below, the measure may at times allow us
to add estimated cost savings and operating synergies related to operational
changes ranging from acquisitions or dispositions to restructuring, and/or
exclude one-time transition expenditures that we anticipate we will need to
incur to realize cost savings before such savings have occurred.

  The calculation of Adjusted EBITDA under our credit agreement as of June 30,
2022, is presented in the table below. However, the results of such calculation
could differ in the future based on the different types of adjustments that may
be included in such respective calculations at the time.

                                       28

--------------------------------------------------------------------------------

Table of Contents

Set forth below is a reconciliation of net income attributable to Zurn common stockholders to Adjusted EBITDA for the periods indicated below.


                                                                      Twelve months
                                                                          ended                                         Twelve months
                                            Six months ended           December 31,           Six months ended              ended
(in millions)                                June 30, 2021                 2021                June 30, 2022            June 30, 2022
Net income attributable to Zurn Elkay
common stockholders                       $           123.2          $       120.9          $            66.6          $        64.3
Income from discontinued operations, net
of tax (1)                                            (92.6)                 (71.2)                      (0.8)                  20.6
Provision for income taxes                             10.9                    2.7                       21.3                   13.1
Actuarial gain on pension and
postretirement benefit obligations                        -                   (1.2)                         -                   (1.2)
Other expense, net (2)                                  0.1                    0.7                        0.3                    0.9
Loss on the extinguishment of debt                        -                   20.4                          -                   20.4
Interest expense                                       19.7                   34.7                          10.0                25.0
Depreciation and amortization                          16.5                   32.7                        9.3                   25.5
EBITDA                                                 77.8                  139.7                      106.7                  168.6
Adjustments to EBITDA
Restructuring and other similar charges
(3)                                                     0.9                    3.7                        1.4                    4.2
Stock-based compensation expense                       16.2                   37.5                        7.7                   29.0
LIFO expense (income) (4)                               4.3                   14.1                       (0.4)                   9.4
Acquisition-related fair value adjustment               0.6                    0.8                        0.6                    0.8
Other, net (5)                                            -                      -                        0.3                    0.3
Subtotal of adjustments to EBITDA                      22.0                   56.1                        9.6                   43.7
Adjusted EBITDA                           $            99.8          $       195.8          $           116.3          $       212.3
Pro forma adjustment for acquisitions (6)                                                                                        0.5
Pro forma Adjusted EBITDA                                                                                                      212.8
Consolidated indebtedness (7)                                                                                          $       442.0
Total net leverage ratio (8)                                                                                                    2.08

__________________________________

(1)Income from discontinued operations, net of tax is not included in Adjusted EBITDA in accordance with the terms of our credit agreement.



(2)Other expense, net for the periods indicated, consists primarily of gains and
losses from foreign currency transactions and the non-service cost components of
net periodic benefit costs associated with our defined benefit plans.

(3)Restructuring and other similar charges is comprised of costs associated with workforce reductions, lease termination costs, and other facility rationalization costs. See Item 1, Note 3, Restructuring and Other Similar Charges for more information.

(4)Last-in first-out (LIFO) inventory adjustments are excluded in calculating Adjusted EBITDA as defined in our credit agreement.

(5)Other, net consists of gains and losses on the disposition of long-lived assets.



(6)Represents a pro forma adjustment to include Adjusted EBITDA related to the
acquisition of Wade Drains, which was permitted by our credit agreement. The pro
forma adjustment includes the period from July 1, 2021, through the date of the
Wade Drains acquisition. See Item 1, Note 2, Acquisitions for more information.

(7)Our credit agreement defines our consolidated indebtedness as the sum of all
indebtedness (other than letters of credit or bank guarantees, to the extent
undrawn) consisting of indebtedness for borrowed money and capitalized lease
obligations, less unrestricted cash, which was $95.5 million (as defined by the
credit agreement) at June 30, 2022.

(8)Our credit agreement defines the total net leverage ratio as the ratio of consolidated indebtedness (as described above) to Adjusted EBITDA for the trailing four fiscal quarters.


                                       29
--------------------------------------------------------------------------------
  Table of Contents
Liquidity and Capital Resources

  Our primary sources of liquidity are available cash and cash equivalents, cash
flow from operations, and borrowing availability of up to $200.0 million under
our revolving credit facility.

  As of June 30, 2022, we had $110.4 million of cash and cash equivalents and
$193.9 million of additional borrowing capacity. As of June 30, 2022, the
available borrowings under our credit facility were reduced by $6.1 million due
to outstanding letters of credit. As of December 31, 2021, we had $96.6 million
of cash and cash equivalents and approximately $193.9 million of additional
borrowing capacity under our revolving credit facility.

Our revolving credit facility is available to fund our working capital requirements, capital expenditures and for other general corporate purposes. We believe this resource is adequate for our expected needs.

Cash Flows

Cash flows for the period ended June 30, 2021 include our continuing operations and discontinued operations for the entire period, while the period ended June 30, 2022 only includes the cash flows associated with continuing operations. Refer to Item 1, Note 4, Discontinued Operations for further information.



Cash (used for) provided by operating activities was $(12.0) million and $145.0
million during the six months ended June 30, 2022 and 2021, respectively. The
change in year over year operating cash flows was primarily the result of higher
trade working capital and the impact of timing of payments on accounts payable
and accrued expenses during the six months ended June 30, 2022.

  Cash provided by investing activities was $35.4 million during the six months
ended June 30, 2022 compared cash used for investing activities of $4.4 million
during the six months ended June 30, 2021. Investing activities during the six
months ended June 30, 2022, included $2.0 million of capital expenditures which
was offset by the receipt of $35.0 million from Regal Rexnord Corporation in
connection with the final net assets transferred in the PMC Spin-Off
Translation, the receipt of $1.3 million in connection with the sale of certain
long-lived assets and the receipt of $1.1 million in connection with finalizing
the acquisition date trade working capital associated with our 2021 acquisition
of Wade Drains. Investing activities during the six months ended June 30, 2021,
primarily included $14.0 million of capital expenditures and a cash payment of
$3.8 million in connection with our acquisition of ATS GREASEwatch, partially
offset by the receipt of $13.0 million in connection with the sale of certain
long-lived assets associated with our discontinued operations and the receipt of
$0.4 million in connection with finalizing the acquisition date trade working
capital associated with our 2020 acquisition of Hadrian.

  Cash used for financing activities was $9.3 million during the six months
ended June 30, 2022, compared to $5.6 million during the six months ended
June 30, 2021. During the six months ended June 30, 2022, we utilized a net $3.0
million of cash for payments on outstanding debt and $7.6 million for the
payment of common stock dividends, which was partially offset by $1.3 million of
proceeds from the exercise of stock options, net of taxes withheld and paid on
employees' share-based awards. During the six months ended June 30, 2021, we
utilized $1.1 million of cash for payments on outstanding debt, $21.6 million
for the payment of common stock dividends and $0.9 million to repurchase common
stock, which was partially offset by $18.0 million of cash proceeds from the
exercise of stock options, net of taxes withheld and paid on employees'
share-based awards.

Indebtedness

As of June 30, 2022, we had $537.5 million of total indebtedness outstanding as follows (in millions):


                      Total Debt at                                        Long-term
                      June 30, 2022       Current Maturities of Debt        Portion
Term loan (1)        $        537.3      $                       5.5      $    531.8

Finance leases                  0.2                              0.1             0.1
Total                $        537.5      $                       5.6      $    531.9

___________________________________________

(1)Includes unamortized debt issuance costs of $10.0 million at June 30, 2022.

See Item 1, Note 13, Long-Term Debt for a description of our outstanding indebtedness.


                                       30

--------------------------------------------------------------------------------

Table of Contents

© Edgar Online, source Glimpses